Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
The IQVIA Value and Access team works to drive engagement between the NHS and the Life Science Industry to facilitate crucial discussions with key decision makers to accelerate and optimise patient access to innovative technologies.
Conduct a landscape analysis to understand the impact of the current healthcare environment
Assess key opportunities for an asset
Define strategies that resonate within the NHS
A trusted, comprehensive report containing expert insights and recommendations on how to maximise the value of your product and ensure patients have access to care in the evolving UK healthcare system, based on the latest health data, guidance and policies
Executives at life science organisations who want to leverage robust insights from the NHS and private market to mitigate threats and maximise opportunities in the strategic planning process
Tailored, intelligence-led insights and recommendations at any stage in your brand journey, powered by unrivalled proprietary data assets, a multidisciplinary team of experts and a unique clinical network
You will be empowered to make more assured, impactful business decisions that optimise the performance of the brand and company
A comprehensive, up-to-date understanding of how the UK healthcare system impacts your business is crucial for strategic planning
IQVIA landscape assessments are powered by unrivalled proprietary data assets and multidisciplinary experts with:
Evidence
Unique access to the most robust insights and data assets in the industry, including:
Data assets: Hospital Episode Statistics (HES), Patient-Level Information and Costing Systems (PLICS), Cancer Analysis System (CAS), OneKey, Pipeline Intelligence Discovery 3.0
Customer insights: NHS Insights Panel, Pando Primary Market Research 360
Expertise
Connected expertise of trusted IQVIA Market Access & Patient Access (MAPA) consultants, Infield market access teams, wider subject matter experts, and a unique network of 110,000 clinicians and managers in the NHS, giving unparalleled breadth and depth of understanding across the healthcare system and life science industry
Experience
Tried and tested methodology, with multiple landscape assessments completed across a range of disease areas in all core life science sectors:
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Private Market Assessment
Have you considered the implications of the Private Healthcare Market in your market access, brand and strategy plans?
The Private Healthcare Market can bring the potential opportunity for the Life Science Industry to capture up to 10% of total revenue within the private sector. An opportunity for the private market to catalyse and accelerate the activation of a much larger opportunity in routine NHS commissioning.
Our IQVIA team discuss the UK Private market and the growing opportunities this brings for the life sciences industry. Watch the full video below with Steve Jowett, Steve Ferguson, Arlene Neville and Orlaith Brennan sharing their insights